Preparation of highly hydrated self-supporting hyaluronic acid
containing films
    5.
    发明授权
    Preparation of highly hydrated self-supporting hyaluronic acid containing films 失效
    高水合自支撑透明质酸含膜的制备

    公开(公告)号:US5618561A

    公开(公告)日:1997-04-08

    申请号:US488049

    申请日:1995-06-07

    摘要: This invention provides new gels in the form of highly hydrated self-supporting film, comprising one or more alkaline alginates, an alkaline earth alginate, a polyalcohol and a hyaluronic acid or a derivative thereof, and their preparation process. These polysaccharide-matrix gels in highly hydrated self-supporting film form are suitable for use as covering and protection materials for cutaneous lesions and/or pathologies in that they are obtainable in self-supporting form in the desired thickness, are transparent, flexible, have good mechanical characteristics, are adaptable to the lesion surface without strongly adhering to it, and are permeable to gas but are impermeable to liquids and bacteria; one or more pharmacologically active substances can also be incorporated in the gel.

    摘要翻译: 本发明提供了具有高度水合的自支撑膜形式的新凝胶,其制备方法包括一种或多种碱性藻酸盐,碱土藻酸盐,多元醇和透明质酸或其衍生物。 这些高度水合的自支撑膜形式的多糖基质凝胶适合用作皮肤损伤和/或病变的覆盖和保护材料,因为它们可以以所需厚度的自支撑形式获得,是透明的,柔性的,具有 良好的机械特性,适应于病变表面而不强烈粘附在其上,并且可渗透气体,但不渗透液体和细菌; 一种或多种药理活性物质也可以掺入凝胶中。

    Water soluble derivatives of biotin and related therapeutical
compositions
    7.
    发明授权
    Water soluble derivatives of biotin and related therapeutical compositions 失效
    生物素水溶性衍生物及相关治疗组合物

    公开(公告)号:US5550249A

    公开(公告)日:1996-08-27

    申请号:US200545

    申请日:1994-02-22

    IPC分类号: C07D495/04 A61K31/38

    CPC分类号: C07D495/04

    摘要: Salts of biotin are described with alkanolamines and the respective water soluble therapeutical compositions, suitable to be orally, parenterally and topically administered.The compositions above are particularly suitable for the treatment of the vitamin H deficiency, having a dermatologic manifestation, for the treatment of the insufficiency in multiple carboxylase enzymes, for the treatment of dermatologic phatologies, like the seborrheal dermatitis in the newborn, and for the treatment of diabetic neuropathies.

    摘要翻译: 用链烷醇胺和各自的水溶性治疗组合物描述生物素的盐,其适合于口服,胃肠外和局部施用。 上述组合物特别适用于治疗具有皮肤病学表现的维生素H缺乏症,用于治疗多种羧化酶的不足,用于治疗皮肤病学类,如新生儿的脂溢性皮炎和治疗 的糖尿病神经病变。

    Modified gangliosides and the functional derivatives thereof
    8.
    发明授权
    Modified gangliosides and the functional derivatives thereof 失效
    改性神经节苷脂及其功能衍生物

    公开(公告)号:US5424294A

    公开(公告)日:1995-06-13

    申请号:US138184

    申请日:1993-10-20

    CPC分类号: C07H15/10

    摘要: N-acyl-N,N'-di-lysogangliosides, N'-acyl-N,N'-di-lysogangliosides and N,N'-diacyl-N,N'-di-lysogangliosides, in which the acyl groups are derived from an organic acid of the aliphatic, aromatic, araliphatic, alicyclic or heterocyclic series and in which at least one of the two acyl groups is not aliphatic, and their preparation are disclosed. Also disclosed is the preparation of the esters, inner esters, amides and hydroxy peracylates of these compounds and salts thereof. These compounds are useful in the treatment of pathologies of the central and peripheral nervous systems.

    摘要翻译: N-酰基-N,N'-二溶菌索双胞苷,N'-酰基-N,N'-二溶菌索双胍和N,N'-二酰基-N,N'-二赖藻糖苷,其中酰基衍生 来自脂族,芳族,芳脂族,脂环族或杂环系列的有机酸,其中两个酰基中的至少一个不是脂族的,并且其公开。 还公开了这些化合物的酯,内酯,酰胺和羟基过酰基化物及其盐的制备。 这些化合物可用于治疗中枢和周围神经系统的病理。

    Lysoganglioside derivatives
    10.
    发明授权
    Lysoganglioside derivatives 失效
    溶血二糖苷衍生物

    公开(公告)号:US06407072B1

    公开(公告)日:2002-06-18

    申请号:US08268730

    申请日:1994-06-30

    IPC分类号: A61K3170

    CPC分类号: C07H15/10

    摘要: Novel N-acyl-lysogangliosides obtained from gangliosides by deacyation of the ceramide group, wherein the acyl group is derived from an aliphatic acid having from 2 to 24 carbon atoms, substituted by one or more polar groups. The N-acyl-lysogangliosides of the invention exhibit an inhibiting action on protein-kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system.

    摘要翻译: 通过神经酰胺基去酰化从神经节苷脂获得的新型N-酰基 - 溶血杆菌二糖苷,其中酰基衍生自具有2至24个碳原子的脂族酸,被一个或多个极性基团取代。 本发明的N-酰基 - 溶血杆菌二糖苷对蛋白激酶C活化具有抑制作用,因此可用于神经系统各种病理学的治疗。